Predictive transcriptomic signature of response to axitinib in patients with advanced NETs included in the randomized, double-blind, placebocontrolled AXINET trial (GETNE 1107)
JOURNAL OF NEUROENDOCRINOLOGY（2023）
Key words
axitinib, tyrosine kinase inhibitor, predictive biomarker, signature
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined